SCHEMBL4011584

SCHEMBL4011584

CC(=O)N(C)c1ccc2sc(C)nc2c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 5/20 0.56
NPC1 O15118 4/20 0.56
SMN1; SMN2 Q16637 4/20 0.56
ALDH1A1 P00352 5/20 0.54
HSD17B10 Q99714 2/20 0.49
MAPT P10636 2/20 0.44
TP53 P04637 2/20 0.44
LDHA P00338 1/20 0.44
PKM P14618 1/20 0.44
HPGD P15428 1/20 0.44
POLB P06746 2/20 0.43
CASP3 P42574 1/20 0.43
SENP7 Q9BQF6 1/20 0.43
TRPV1 Q8NER1 1/20 0.43
GAA P10253 1/20 0.42
HDAC4 P56524 1/20 0.41
KMT2A Q03164 1/20 0.41
DYRK1A Q13627 1/20 0.41
TDP1 Q9NUW8 2/20 0.40
LMNA P02545 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4507446 0.88 LDHA (0.55) RAB9ANPC1SMN1; SMN2ALDH1A1HSD17B10
SCHEMBL14485659 0.88 RAB9A (0.60) RAB9ANPC1SMN1; SMN2ALDH1A1HSD17B10
SCHEMBL14554619 0.81 PAX8 (0.56) RAB9ANPC1SMN1; SMN2ALDH1A1HSD17B10
SCHEMBL3255931 0.80 ALDH1A1 (0.58) RAB9ANPC1SMN1; SMN2ALDH1A1HSD17B10
SCHEMBL13480972 0.79 CA2 (0.58)
SCHEMBL8033758 0.79 RAB9A (0.50) RAB9ANPC1SMN1; SMN2ALDH1A1HSD17B10
SCHEMBL4468091 0.77 MAPT (0.52) RAB9ANPC1SMN1; SMN2ALDH1A1HSD17B10
SCHEMBL5335865 0.76 NPC1 (0.50) RAB9ANPC1SMN1; SMN2ALDH1A1HSD17B10
SCHEMBL18173872 0.75 ALDH1A1 (0.41) RAB9ANPC1SMN1; SMN2ALDH1A1HSD17B10
SCHEMBL20481983 0.74 NPC1 (0.78) RAB9ANPC1SMN1; SMN2ALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009085226-A2 INHIBITORS OF CDC2-LIKE KINASES (CLKS) AND METHODS OF USE THEREOF SIRTRIS PHARMACEUTICALS, INC. (US) 2009-07-09 WO disclosed
WO-2009085226-A2 INHIBITORS OF CDC2-LIKE KINASES (CLKS) AND METHODS OF USE THEREOF SIRTRIS PHARMACEUTICALS, INC. (US) 2009-07-09 WO disclosed